A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System

Completed

Conditions studied: Lung Cancer, Lung Neoplasms, Cancer of Lung, Cancer of the Lung, Neoplasms, Lung, Neoplasms, Pulmonary, Pulmonary Cancer, Pulmonary Neoplasms, Carcinoma, Non-small-cell Lung, Adenocarcinoma, Squamous Cell Carcinoma

In brief

The purpose of this study is to isolate and measure circulating tumor cells in the blood stream to advance detection of cancer and treatment monitoring. In this study, the investigators will utilize the novel technology for circulating tumor cell detection in order to evaluate their presence in patients with lung cancer.

Key facts

Study ID

NCT02370303

Run by

Mayo Clinic

People needed

23

Starts

2014-08-01

Expected to finish

2016-07-09

Last updated by the study team

2018-03-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Stage IB and above non-small cell lung cancer or metastatic lung cancer
• Age >18 years old
• Willing and able to consent to study
• No prior history of neoadjuvant therapy.

You may not qualify if…

• Age <18 years old
• Unable to provide consent

Where it is running

• Mayo Clinic in Rochester — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.